Changing Clinical Practice with Measurements of Portal Pressure

Hepatology

Volumn 39, Issue 2, 2004, Pages 283-285

  Boyer, Thomas D ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NITRIC ACID DERIVATIVE;

BLEEDING; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; HEMODYNAMIC MONITORING; HEPATIC VEIN; HUMAN; INTENSIVE CARE; INTERVENTIONAL RADIOLOGY; LIVER CIRRHOSIS; MEASUREMENT; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRESSURE GRADIENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; TRANSDUCER; TREATMENT FAILURE; VARICOSIS; VENOUS PRESSURE;

HUMANS; HYPERTENSION, PORTAL; PORTAL VEIN; TRANSDUCERS; VENOUS PRESSURE;

EID: 1242314393     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20037     Document Type: Review

References (26)

1. Boyer TD, Henderson JM. Portal hypertension and bleeding esophageal varices. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: Saunders, 2003:581-630.
2. Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia P, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. HEPATOLOGY 1999;30:1393-1397.
3. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977;72:584-589.
4. Boyer T. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003;124:1700-1710.
5. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-954.
6. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626-631.
7. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. The American Journal of Gastroenterology 2003;98:653-659.
8. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505.
9. Boyer TD. Pharmacologic treatment of portal hypertension: past, present, and future. HEPATOLOGY 2001;34:834-839.
10. Garcia-Pagan SC, Grace NO. Primary prophylaxis. In: de Franchis R, ed. Portal Hypertension III. Oxford, UK: Blackwell Science Ltd., 2001:127-131.
11. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 1997;92:1081-1091.
12. Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 2002;97:2441-2452.
13. Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective? HEPATOLOGY 2003;37:366-377.
14. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. HEPATOLOGY 2000;32:930-934.
15. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-1407.
16. Bureau C, Jean M, Alric Laurent, Morales J, Sanchez J, Barange K, et al. "A La Carte" treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. HEPATOLOGY 2002;36:1361-1366.
17. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. HEPATOLOGY 1997;26:34-39.
18. Garcia-Pagan JC, Morillas R, Banares R, Albillos A, Villanueva C, Vila C, et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. HEPATOLOGY 2003;37:1260-1266.
19. Merkel C. Nonselective β-blockers plus nitrates in portal hypertension: an open question. HEPATOLOGY 2003;37:1254-1256.
20. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345:669-681.
21. Patch D, Goulis J, Gerunda G, Greenslade L, Merkel C, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-1019.
22. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-655.
23. Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. HEPATOLOGY 2000;32:461-465.
24. Patch D, Armonis A, Sabin C, Christopoulou K, Greenslade L, McCormick A, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999;44:264-269.
25. Imperiale T, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. HEPATOLOGY 2001;33:802-807.
26. Hicken BL, Sharara AI, Abrams GA, Eloubeidi M, Fallon MB, Arguedas MR. Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study. Aliment Pharmacol Ther 2003;17:145-153.